Matthew, Partner, is a Chartered Patent Attorney and European Patent Attorney and heads up our Cambridge Biotechnology and Life Sciences Group.
Matthew specialises in the preparation and prosecution of patent applications in the biotechnology, pharmaceuticals, biologics and healthcare fields. He regularly provides due diligence and freedom-to-operate advice to his clients in various technical areas and has particular expertise in diagnostic technologies; specifically biomarkers and personalised medicine, especially companion diagnostics, therapeutics including biologics, analyte detection technologies (including bacterial detection), pest control, fermentation processes, stem cell technologies and medical devices. He brings strategic and commercial advice to his clients and has extensive experience of supporting early stage companies seeking investment and development partners. He has also worked on a Patent Attorney’s Report for an Initial Public Offering of a pharmaceutical company specialising in plant derived medicines.
Matthew is highly experienced in developing drafting and prosecution strategies for key client portfolios worldwide. He regularly represents his clients in Oral Proceedings before the Opposition and Appeal Boards of the European Patent Office.
Matthew tutors candidates in preparation for British and European final examinations and also speaks and publishes on various aspects of biotechnology and healthcare patenting. He has an MA Cantab (Natural Sciences) from Cambridge University which focused on biochemistry, molecular cell biology, chemistry and plant sciences and enables Matthew to practice in a wide range of biochemical and chemical technology areas. He also has an MSci Biochemistry also from Cambridge University in which Matthew engineered protein isoforms of a splicing regulator protein. He has a postgraduate certificate in Intellectual Property Law from Queen Mary & Westfield College, University of London and was awarded the Chartered Institute of Patent Agents Drafting prize for his performance in the finals examination.
- Represented Adaptive Biotechnologies Corporation in European opposition proceedings and successfully defended European Patent No. 2 364 368 which provides broad protection for immune profiling using next-generation sequencing (NGS).
- Successfully opposed a series of third party patents for a company that makes biomedical laboratory instruments.
- Assisted a biofuel producer with a long-running entitlement dispute, which was resolved in its favour following litigation in the IPEC.
BIO International Convention, Speaker, San Diego, US, June 2017
MIP International Patent Forum 2016, London, March 2016
CIPA Life Sciences conference, November 2015
Festival of Geonomics – Workshop organisers: Freedom to Operate, California, November 2015
February 2015 – One Nucleus Life Sciences Leadership Series – Cancer Immunotherapies
January 2014 – BIA Gala Dinner
October 2014 – EPIC Biotech
July 2014 – One Nucleus, ON Helix
June 2014 – BIO International Convention, San Diego
May 2014 – One Nucleus Life Sciences Leadership Series – Personalised medicine
May 2014 – BIA Lecture, ‘Inspiring innovation in healthcare and the next generation’
April 2014 – M11 Med Tech Forum
March 2014 – Host and presenter, ‘Patent eligibility issues particularly in the area of personalised medicine’, One Nucleus breakfast meeting
February 2014 – Speaker, Boult Wade Tennant Chemistry and Biotech client seminar
January 2014 – BIA Gala Dinner
Biotechnology and Life Sciences
CPC4 Capital Park
Sectors and practice areas
- Medical devices
- Cancer immunotherapies
- Companion diagnostics
- Enzymatic detection
- Gene therapy
- Molecular biology
- Nucleic acid based technologies
- Plant derived pharmaceuticals
- Proteins and peptides therapeutics
- RNAi in plants
- Small molecule imaging agents
- One Nucleus
- Chartered UK Patent Attorney (awarded the Chartered Institute of Patent Attorneys Drafting prize)
- European Patent Attorney
- MA (Cantab) Natural Sciences, University of Cambridge
- MSci Biochemistry, University of Cambridge
Legal 500, 2012 (Recommended, Patent Attorneys)
Find another attorney